© 1996 by Oxford University Press
Journal of the National Cancer Institute, Vol. 88, No. 5, 279-284,
March 6, 1996
© 1996 Oxford University Press
Role of c-myc in Tamoxifen-Induced Apoptosis in Estrogen-Independent Breast Cancer Cells
Division of Surgical Oncology, Eastern Virginia Medical School Norfolk
Correspondence to: Roger R. Perry, M.D., Eastern Virginia Medical School, 825 Fairfax Ave., Suite 610, Norfolk. VA 23507-1912.
BACKGROUND: The antiestrogen tamoxifen (TAM) is effective in the treatment of estrogen receptor (ER)-positive as well as some ER-negative breast cancers. However, the precise mechanism of action of TAM, especially in estrogen-independent cells, remains unclear. Previous work by our laboratory has demonstrated that TAM induces the morphologic and biochemical changes that are characteristic of apoptosis in both ER-positive and ER-negative cells.
PURPOSE: We compared the effect of TAM at a clinically achievable concentration on cell growth and apoptosis with the effect of TAM on c-myc (also known as C-MYC) messenger RNA (mRNA) and protein expression in ER-negative MDA-231 cells.
METHODS: MDA-231 cells were treated for up to 72 hours with 1.0 µM TAM alone or in the presence of 50 µM c-myc antisense or nonsense oligonucleotides. c-myc mRNA expression was determined by northern blot analysis, protein expression by western blot analysis, cell growth inhibition by cell counts, and DNA cleavage by agarose gel electrophoretic analysis. Differences between the mean values from different treatment groups were compared with the use of the two-sided Wilcoxon rank-sum test. Results: TAM treatment for 72 hours increased c-myc mRNA five-fold (from a relative radiolabeled hybridization signal intensity of 17 ± 4 up to 93 ± 10; P<.05) and c-Myc protein threefold (from a relative immuno-fluorescence signal intensity of 28 ± 7 up to 83 ± 21; P<.05). The induction of c-myc by TAM was accompanied by internucleosomal DNA cleavage characteristic of apoptotic cell death. Addition of c-myc antisense oligonucleotide (5'-CACGTTGAGGGGCAT-3') to MDA-231 cells resulted in a nearly twofold decrease of basal c-myc mRNA (P<.05) and a sevenfold decrease of basal c-Myc protein (P<.05) expression. Addition of c-myc antisense oligomer also antagonized the TAM-induced increase in c-myc mRNA (P<.05) and protein expression (P<.05) and inhibited TAM-induced cytostasis (P<.01) and apoptosis. In parallel experiments, addition of the nonsense oligomer had no effect on any of the measured parameters.
CONCLUSIONS: These results indicate that the effects of TAM on ER-negative MDA-231 cells may be mediated through c-myc overexpression. c-myc may play a critical role in the growth and progression of MDA-231 breast cancer cells. [J Natl Cancer Inst 1996;88:279–84]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Kalra and V. Kumar c-Fos Is a Mediator of the c-Myc-induced Apoptotic Signaling in Serum-deprived Hepatoma Cells via the p38 Mitogen-activated Protein Kinase Pathway J. Biol. Chem., June 11, 2004; 279(24): 25313 - 25319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Sun, N. Hail Jr, and R. Lotan Apoptosis as a Novel Target for Cancer Chemoprevention J Natl Cancer Inst, May 5, 2004; 96(9): 662 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Tangkeangsirisin, J. Hayashi, and G. Serrero PC Cell-Derived Growth Factor Mediates Tamoxifen Resistance and Promotes Tumor Growth of Human Breast Cancer Cells Cancer Res., March 1, 2004; 64(5): 1737 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Khalkhali-Ellis, A. L. Christian, D. A. Kirschmann, E. M. Edwards, M. Rezaie-Thompson, M. A. Vasef, L. M. Gruman, R. E. B. Seftor, L. E. Norwood, and M. J. C. Hendrix Regulating the Tumor Suppressor Gene Maspin in Breast Cancer Cells: A Potential Mechanism for the Anticancer Properties of Tamoxifen Clin. Cancer Res., January 15, 2004; 10(2): 449 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Obrero, D. V. Yu, and D. J. Shapiro Estrogen Receptor-dependent and Estrogen Receptor-independent Pathways for Tamoxifen and 4-Hydroxytamoxifen-induced Programmed Cell Death J. Biol. Chem., November 15, 2002; 277(47): 45695 - 45703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Carroll, A. Swarbrick, E. A. Musgrove, and R. L. Sutherland Mechanisms of Growth Arrest by c-myc Antisense Oligonucleotides in MCF-7 Breast Cancer Cells: Implications for the Antiproliferative Effects of Antiestrogens Cancer Res., June 1, 2002; 62(11): 3126 - 3131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Choi, S. K. Kang, C.-J. Tai, N. Auersperg, and P. C. K. Leung Estradiol Up-Regulates Antiapoptotic Bcl-2 Messenger Ribonucleic Acid and Protein in Tumorigenic Ovarian Surface Epithelium Cells Endocrinology, June 1, 2001; 142(6): 2351 - 2360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mandlekar, R. Yu, T.-H. Tan, and A.-N. T. Kong Activation of Caspase-3 and c-Jun NH2-terminal Kinase-1 Signaling Pathways in Tamoxifen-induced Apoptosis of Human Breast Cancer Cells Cancer Res., November 1, 2000; 60(21): 5995 - 6000. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Pan, S. M. Vickers, A. Pickens, J. O. Phillips, W. Ying, J. A. Thompson, G. P. Siegal, and J. M. McDonald Apoptosis and Tumorigenesis in Human Cholangiocarcinoma Cells : Involvement of Fas/APO-1 (CD95) and Calmodulin Am. J. Pathol., July 1, 1999; 155(1): 193 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bieche, I. Laurendeau, S. Tozlu, M. Olivi, D. Vidaud, R. Lidereau, and M. Vidaud Quantitation of MYC Gene Expression in Sporadic Breast Tumors with a Real-Time Reverse Transcription-PCR Assay Cancer Res., June 1, 1999; 59(12): 2759 - 2765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sukhu, B. Rotenberg, C. Binkert, H. Kohno R. ZOHAR, C. A. G. McCulloch, and H. C. Tenenbaum Tamoxifen Attenuates Glucocorticoid Actions on Bone Formation in Vitro Endocrinology, August 1, 1997; 138(8): 3269 - 3275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Spyridopoulos, A. B. Sullivan, M. Kearney, J. M. Isner, and D. W. Losordo Estrogen-Receptor–Mediated Inhibition of Human Endothelial Cell Apoptosis : Estradiol as a Survival Factor Circulation, March 18, 1997; 95(6): 1505 - 1514. [Abstract] [Full Text]
|
|